PARIS: A long-term study of women who used ovary-stimulating hormones for fertility treatment found no widespread evidence of a higher cancer risk, researchers said on Monday.
The results appear to contradict a number of studies in recent years that suggested such treatments may increase the risk of the disease.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.